Skip to content

Clinical trials

Urologic Diseases trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urologic Diseases Country / region: Israel Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20121
20133
20141
20182
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting1
Recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UroGen Pharma Ltd.3
Alnylam Pharmaceuticals1
Astellas Pharma Europe Ltd.1
Medical Enterprises Europe B.V.1
Medtronic1
Novartis Pharmaceuticals1
Novo Nordisk A/S1
Omri Schwarztuch Gildor1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urologic Diseases10
Urinary Bladder Diseases5
Non-Muscle Invasive Bladder Neoplasms4
Urinary Bladder Neoplasms4
Urologic Neoplasms4
Kidney Diseases3
Neoplasms3
Genetic Diseases, Inborn2
Hyperoxaluria, Primary2
Neoplasms by Site2

Trials

Showing 76 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.